Loading…

Ypsomed opened its first dedicated production site in Changzhou, China, with an investment of nearly CHF 150 million. The facility will manufacture up to 100 million injection systems annually for the Chinese market.
“Opening our own factory in China is not just a strategic investment – it reflects our long-term commitment and confidence in the Chinese market.”ypsomed.com
Summarized from public sources; check the original articles before acting on it.